Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study
| Autor: | P, Gantner, L, Cuzin, C, Allavena, A, Cabie, P, Pugliese, M-A, Valantin, F, Bani-Sadr, V, Joly, T, Ferry, I, Poizot-Martin, R, Garraffo, G, Peytavin, S, Fafi-Kremer, D, Rey, D, Lebrun |
|---|---|
| Přispěvatelé: | Epidémiologie et analyses en santé publique : risques, maladies chroniques et handicaps (LEASP), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées |
| Rok vydání: | 2017 |
| Předmět: |
0301 basic medicine
Oncology Male medicine.medical_specialty Anti-HIV Agents Pyridones [SDV]Life Sciences [q-bio] 030106 microbiology HIV Infections Piperazines Cohort Studies 03 medical and health sciences chemistry.chemical_compound Internal medicine Oxazines medicine Humans Pharmacology (medical) Dual therapy ComputingMilieux_MISCELLANEOUS Retrospective Studies business.industry Health Policy Rilpivirine Middle Aged 3. Good health Infectious Diseases Treatment Outcome chemistry Dolutegravir HIV-1 Drug Therapy Combination Female business Heterocyclic Compounds 3-Ring Cohort study |
| Zdroj: | HIV Medicine HIV Medicine, Wiley, 2017, ⟨10.1111/hiv.12506⟩ |
| ISSN: | 1468-1293 1464-2662 |
| Popis: | International audience |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|